Talis Biomedical Corporation (TLIS) Earnings
|
Expand Research on TLIS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -52.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/19/24  |
Q224 | N/A | -$5.91 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/19/24 |
Q224 | N/A | -$5.91 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/19/24 |
Q224 | N/A | -$5.91 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/13/23 | Q323 | N/A | -$9.29 | N/A | N/A | $102.5K | N/A | N/A | N/A | ||
| 8/10/23 | Q223 | -$8.27 | -$9.58 | +$1.31 | $580K | $102.5K | N/A |  | | Details | |
| 5/11/23 | Q123 | $0.00 | -$0.73 | +$0.73 | $1.2M | $230K | N/A | | | Details | |
| 3/20/23 | Q422 | N/A | -$0.68 | N/A | N/A | $780K | N/A | N/A | N/A | ||
| 3/14/23 | Q422 | N/A | -$0.68 | N/A | N/A | $780K | N/A | N/A | N/A |
